×
About 53,154 results

ALLMedicine™ Migraine Center

Research & Reviews  22,725 results

Lasmiditan for the acute treatment of migraine.
https://doi.org/10.2217/pmt-2021-0002
Pain Management; DeJulio PA, Perese JK et. al.

Apr 12th, 2021 - Migraine is a leading cause of morbidity and disability worldwide. Triptans were the first migraine-specific drug class developed and have proven efficacy in treatment of this neurological disease. They are however contraindicated in patients with...

Targets for migraine treatment: beyond calcitonin gene-related peptide.
https://doi.org/10.1097/WCO.0000000000000935
Current Opinion in Neurology; Moreno-Ajona D, Villar-Martínez MD et. al.

Apr 12th, 2021 - Despite the development of several medications for the acute and preventive treatment of migraine, there are still many patients in whom lack of efficacy, tolerability, interactions or contraindications make other options necessary. CGRP-based dru...

A 2021 update on migraine.
https://doi.org/10.1097/WCO.0000000000000939
Current Opinion in Neurology; Green MW

Apr 12th, 2021 - A 2021 update on migraine.|2021|Green MW,|

Are 5-HT1 receptor agonists effective anti-migraine drugs?
https://doi.org/10.1080/14656566.2021.1910235
Expert Opinion on Pharmacotherapy; Tanaka M, Török N et. al.

Apr 12th, 2021 - Are 5-HT1 receptor agonists effective anti-migraine drugs?|2021|Tanaka M,Török N,Vécsei L,|

Depression, Anxiety and Stress in Saudi Migraine patients using DASS-21: Local Populati...
https://doi.org/10.1080/00207454.2021.1909011
The International Journal of Neuroscience; Al-Hayani M, AboTaleb H et. al.

Apr 12th, 2021 - Background: Psychiatric comorbidity is common among migraineurs, such as anxiety and depression. This type of comorbidity contributed to migraine chronicity, management efficacy, and increasing the risk for other comorbidities. This study designed...

see more →

Guidelines  55 results

ACR Appropriateness Criteria® Cerebrovascular Disease-Child.
https://doi.org/10.1016/j.jacr.2020.01.036
Journal of the American College of Radiology : JACR; , Robertson RL et. al.

May 6th, 2020 - Stroke is an uncommon but an important and under-recognized cause of morbidity and mortality in children. Strokes may be due to either brain ischemia or intracranial hemorrhage. Common symptoms of pediatric acute stroke include headache, vomiting,...

Pharmacologic Acute and Preventive Treatment for Migraine in Children and Adolescents.
https://doi.org/10.1001/jamaneurol.2019.4170
JAMA Neurology; Szperka CL, VanderPluym JH et. al.

Dec 9th, 2019 - Pharmacologic Acute and Preventive Treatment for Migraine in Children and Adolescents.|2019|Szperka CL,VanderPluym JH,Oakley CB,|prevention & control,

Acupuncture for Pain
https://www.aafp.org/afp/2019/0715/p89.html
American Family Physician; Kelly,R.,et al

Jul 14th, 2019 - Acupuncture has been increasingly used as an integrative or complementary therapy for pain. It is well-tolerated with little risk of serious adverse effects. Traditional acupuncture and nontraditional techniques, such as electroacupuncture and dry...

Association Between Food Insecurity and Migraine Among US Young Adults
https://jamanetwork.com/journals/jamaneurology/article-abstract/2736340
JAMA Neurology; Nagata,J.,et al

Jun 23rd, 2019 - Food insecurity, defined as limited or intermittent access to nutritionally adequate and safe foods, accessed in socially acceptable ways, is associated with numerous adverse physical and mental health outcomes.1 One in 6 individuals are affected ...

Aids to management of headache disorders in primary care (2nd edition) : on behalf of t...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6734476
The Journal of Headache and Pain; Steiner TJ, Jensen R et. al.

May 22nd, 2019 - The Aids to Management are a product of the Global Campaign against Headache, a worldwide programme of action conducted in official relations with the World Health Organization. Developed in partnership with the European Headache Federation, they ...

see more →

Drugs  1,229 results see all →

Clinicaltrials.gov  25,783 results

Lasmiditan for the acute treatment of migraine.
https://doi.org/10.2217/pmt-2021-0002
Pain Management; DeJulio PA, Perese JK et. al.

Apr 12th, 2021 - Migraine is a leading cause of morbidity and disability worldwide. Triptans were the first migraine-specific drug class developed and have proven efficacy in treatment of this neurological disease. They are however contraindicated in patients with...

Targets for migraine treatment: beyond calcitonin gene-related peptide.
https://doi.org/10.1097/WCO.0000000000000935
Current Opinion in Neurology; Moreno-Ajona D, Villar-Martínez MD et. al.

Apr 12th, 2021 - Despite the development of several medications for the acute and preventive treatment of migraine, there are still many patients in whom lack of efficacy, tolerability, interactions or contraindications make other options necessary. CGRP-based dru...

A 2021 update on migraine.
https://doi.org/10.1097/WCO.0000000000000939
Current Opinion in Neurology; Green MW

Apr 12th, 2021 - A 2021 update on migraine.|2021|Green MW,|

Are 5-HT1 receptor agonists effective anti-migraine drugs?
https://doi.org/10.1080/14656566.2021.1910235
Expert Opinion on Pharmacotherapy; Tanaka M, Török N et. al.

Apr 12th, 2021 - Are 5-HT1 receptor agonists effective anti-migraine drugs?|2021|Tanaka M,Török N,Vécsei L,|

Depression, Anxiety and Stress in Saudi Migraine patients using DASS-21: Local Populati...
https://doi.org/10.1080/00207454.2021.1909011
The International Journal of Neuroscience; Al-Hayani M, AboTaleb H et. al.

Apr 12th, 2021 - Background: Psychiatric comorbidity is common among migraineurs, such as anxiety and depression. This type of comorbidity contributed to migraine chronicity, management efficacy, and increasing the risk for other comorbidities. This study designed...

see more →

News  3,295 results

Green Light May Put a Stop to Migraine
https://www.medscape.com/viewarticle/948973

Apr 7th, 2021 - Patients with migraine experienced about a 60% reduction in pain intensity and number of headache days per month after exposure to green light therapy, according to results of a small study from the University of Arizona, Tucson. "This is the firs...

Triple Threat: Three Common Symptoms Add Up to One Rare Condition
https://www.medscape.com/viewarticle/948033

Mar 23rd, 2021 - When a 39-year-old previously healthy woman with blurred vision, hearing loss, and migraine presented to the emergency department (ED) at St. Michael's Hospital in Toronto, Canada, Sanskriti Sasikumar, MD, knew a multidisciplinary approach was nee...

Many Nonpharmacological Options to Treat Pediatric Migraine
https://www.medscape.com/viewarticle/947384

Mar 14th, 2021 - (Reuters Health) - A wide range of nonpharmacological interventions may be effective for pediatric migraine, a systematic review and meta-analysis suggests. Researchers examined data from 12 randomized controlled trials that included 576 children ...

Post-Traumatic Migraine Tied to Longer Recovery After Youth Concussion
https://www.medscape.com/viewarticle/947065

Mar 10th, 2021 - (Reuters Health) - Youth who sustain mild traumatic brain injuries may have a longer recovery when they experience migraines than with other types of post-traumatic headache, a new study suggests. Researchers examined data on 281 youth ranging in ...

Cannabis for Migraine Strongly Linked to Rebound Headache
https://www.medscape.com/viewarticle/947086

Mar 8th, 2021 - Patients with chronic migraine who turn to cannabis to relieve headache pain may be setting themselves up for medication overuse headache, preliminary research suggests, although the direction of the relationship is unclear. Researchers at Stanfor...

see more →

Patient Education  67 results see all →